vs

Side-by-side financial comparison of Clearfield, Inc. (CLFD) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $32.6M, roughly 1.1× RxSight, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -28.1%, a 26.3% gap on every dollar of revenue. On growth, Clearfield, Inc. posted the faster year-over-year revenue change (-3.2% vs -18.9%). RxSight, Inc. produced more free cash flow last quarter ($-2.3M vs $-2.4M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs -3.5%).

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

CLFD vs RXST — Head-to-Head

Bigger by revenue
CLFD
CLFD
1.1× larger
CLFD
$34.3M
$32.6M
RXST
Growing faster (revenue YoY)
CLFD
CLFD
+15.7% gap
CLFD
-3.2%
-18.9%
RXST
Higher net margin
CLFD
CLFD
26.3% more per $
CLFD
-1.8%
-28.1%
RXST
More free cash flow
RXST
RXST
$175.0K more FCF
RXST
$-2.3M
$-2.4M
CLFD
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
-3.5%
CLFD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLFD
CLFD
RXST
RXST
Revenue
$34.3M
$32.6M
Net Profit
$-614.0K
$-9.2M
Gross Margin
33.2%
77.5%
Operating Margin
-5.3%
-34.8%
Net Margin
-1.8%
-28.1%
Revenue YoY
-3.2%
-18.9%
Net Profit YoY
67.8%
-54.1%
EPS (diluted)
$-0.04
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLFD
CLFD
RXST
RXST
Q4 25
$34.3M
$32.6M
Q3 25
$23.4M
$30.3M
Q2 25
$49.9M
$33.6M
Q1 25
$47.2M
$37.9M
Q4 24
$29.7M
$40.2M
Q3 24
$5.6M
$35.3M
Q2 24
$48.8M
$34.9M
Q1 24
$36.9M
$29.5M
Net Profit
CLFD
CLFD
RXST
RXST
Q4 25
$-614.0K
$-9.2M
Q3 25
$-9.1M
$-9.8M
Q2 25
$1.6M
$-11.8M
Q1 25
$1.3M
$-8.2M
Q4 24
$-1.9M
$-5.9M
Q3 24
$-6.3M
Q2 24
$-447.0K
$-6.1M
Q1 24
$-5.9M
$-9.1M
Gross Margin
CLFD
CLFD
RXST
RXST
Q4 25
33.2%
77.5%
Q3 25
53.2%
79.9%
Q2 25
30.5%
74.9%
Q1 25
30.1%
74.8%
Q4 24
29.2%
71.6%
Q3 24
71.4%
Q2 24
21.9%
69.5%
Q1 24
7.7%
70.1%
Operating Margin
CLFD
CLFD
RXST
RXST
Q4 25
-5.3%
-34.8%
Q3 25
10.3%
-40.1%
Q2 25
3.0%
-41.6%
Q1 25
0.6%
-28.2%
Q4 24
-6.9%
-21.5%
Q3 24
-26.1%
Q2 24
-4.7%
-23.9%
Q1 24
-26.4%
-36.2%
Net Margin
CLFD
CLFD
RXST
RXST
Q4 25
-1.8%
-28.1%
Q3 25
-38.8%
-32.4%
Q2 25
3.2%
-35.0%
Q1 25
2.8%
-21.6%
Q4 24
-6.4%
-14.8%
Q3 24
-17.9%
Q2 24
-0.9%
-17.4%
Q1 24
-16.0%
-30.8%
EPS (diluted)
CLFD
CLFD
RXST
RXST
Q4 25
$-0.04
$-0.22
Q3 25
$-0.65
$-0.24
Q2 25
$0.11
$-0.29
Q1 25
$0.09
$-0.20
Q4 24
$-0.13
$-0.14
Q3 24
$-0.16
Q2 24
$-0.04
$-0.16
Q1 24
$-0.40
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLFD
CLFD
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$96.4M
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$249.7M
$275.7M
Total Assets
$268.1M
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLFD
CLFD
RXST
RXST
Q4 25
$96.4M
$228.1M
Q3 25
$106.0M
$227.5M
Q2 25
$117.2M
$227.5M
Q1 25
$112.0M
$229.3M
Q4 24
$113.0M
$237.2M
Q3 24
$129.0M
$237.1M
Q2 24
$123.8M
$233.3M
Q1 24
$142.9M
$125.4M
Total Debt
CLFD
CLFD
RXST
RXST
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$2.2M
Q2 24
$2.1M
Q1 24
Stockholders' Equity
CLFD
CLFD
RXST
RXST
Q4 25
$249.7M
$275.7M
Q3 25
$256.2M
$276.0M
Q2 25
$264.5M
$278.0M
Q1 25
$265.9M
$279.3M
Q4 24
$267.4M
$281.2M
Q3 24
$275.8M
$277.3M
Q2 24
$274.6M
$275.2M
Q1 24
$279.2M
$163.9M
Total Assets
CLFD
CLFD
RXST
RXST
Q4 25
$268.1M
$311.8M
Q3 25
$306.2M
$308.5M
Q2 25
$314.7M
$309.0M
Q1 25
$310.9M
$313.0M
Q4 24
$303.2M
$318.6M
Q3 24
$315.3M
$310.5M
Q2 24
$318.1M
$305.5M
Q1 24
$315.4M
$183.2M
Debt / Equity
CLFD
CLFD
RXST
RXST
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.01×
Q2 24
0.01×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLFD
CLFD
RXST
RXST
Operating Cash FlowLast quarter
$-1.4M
$-1.1M
Free Cash FlowOCF − Capex
$-2.4M
$-2.3M
FCF MarginFCF / Revenue
-7.1%
-6.9%
Capex IntensityCapex / Revenue
2.9%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLFD
CLFD
RXST
RXST
Q4 25
$-1.4M
$-1.1M
Q3 25
$-1.2M
Q2 25
$7.9M
$-4.4M
Q1 25
$3.0M
$-8.8M
Q4 24
$7.2M
$-4.3M
Q3 24
$22.2M
$650.0K
Q2 24
$4.0M
$-4.0M
Q1 24
$-5.7M
$-9.3M
Free Cash Flow
CLFD
CLFD
RXST
RXST
Q4 25
$-2.4M
$-2.3M
Q3 25
$-1.8M
Q2 25
$7.5M
$-5.9M
Q1 25
$654.0K
$-9.4M
Q4 24
$5.1M
$-5.1M
Q3 24
$18.2M
$-453.0K
Q2 24
$2.8M
$-5.5M
Q1 24
$-7.7M
$-11.3M
FCF Margin
CLFD
CLFD
RXST
RXST
Q4 25
-7.1%
-6.9%
Q3 25
-5.8%
Q2 25
15.1%
-17.6%
Q1 25
1.4%
-24.8%
Q4 24
17.1%
-12.7%
Q3 24
323.0%
-1.3%
Q2 24
5.8%
-15.9%
Q1 24
-20.8%
-38.2%
Capex Intensity
CLFD
CLFD
RXST
RXST
Q4 25
2.9%
3.5%
Q3 25
2.0%
1.9%
Q2 25
0.8%
4.6%
Q1 25
5.1%
1.5%
Q4 24
7.0%
2.1%
Q3 24
71.4%
3.1%
Q2 24
2.5%
4.4%
Q1 24
5.3%
6.7%
Cash Conversion
CLFD
CLFD
RXST
RXST
Q4 25
Q3 25
Q2 25
4.93×
Q1 25
2.30×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLFD
CLFD

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons